Modeling the impact of early vaccination in an influenza pandemic in the United States

We modeled the impact of initiating one-dose influenza vaccination at 3 months vs 6 months after declaration of a pandemic over a 1-year timeframe in the US population. Three vaccine effectiveness (VE) and two pandemic severity levels were considered, using an epidemic curve based on typical seasonal influenza epidemics. Vaccination from 3 months with a high, moderate, or low effectiveness vaccine would prevent ~95%, 84%, or 38% deaths post-vaccination, respectively, compared with 21%, 18%, and 8%, respectively following vaccination at 6 months, irrespective of pandemic severity. While the pandemic curve would not be flattened from vaccination from 6 months, a moderate/high effectiveness vaccine could flatten the curve if administered from 3 months. Overall, speed of initiating a vaccination campaign is more important than VE in reducing the health impacts of an influenza pandemic. Preparedness strategies may be able to minimize future pandemic impacts by prioritizing rapid vaccine roll-out.

Authors

Institutions

Publication Details

Journal
npj Vaccines
Published
2025-03-29
DOI
https://doi.org/10.1038/s41541-025-01081-5
Citations
3
Primary Topic
COVID-19 epidemiological studies
Type
article
Field-Weighted Citation Impact
4.10

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modeling the impact of early vaccination in an influenza pandemic in the United States

Charles H. Jones, Verna Welch, B. Adam Williams, Pascal Crépey et al.
3 citations
npj Vaccines
COVID-19 epidemiological studies
4.10
article

Modeling the impact of early vaccination in an influenza pandemic in the United States

Charles H. Jones, Verna Welch, B. Adam Williams, Pascal Crépey, Jane M. True, Văn Hùng Nguyễn, Jean Marie Pivette
article en
3 citations

Abstract

We modeled the impact of initiating one-dose influenza vaccination at 3 months vs 6 months after declaration of a pandemic over a 1-year timeframe in the US population. Three vaccine effectiveness (VE) and two pandemic severity levels were considered, using an epidemic curve based on typical seasonal influenza epidemics. Vaccination from 3 months with a high, moderate, or low effectiveness vaccine would prevent ~95%, 84%, or 38% deaths post-vaccination, respectively, compared with 21%, 18%, and 8%, respectively following vaccination at 6 months, irrespective of pandemic severity. While the pandemic curve would not be flattened from vaccination from 6 months, a moderate/high effectiveness vaccine could flatten the curve if administered from 3 months. Overall, speed of initiating a vaccination campaign is more important than VE in reducing the health impacts of an influenza pandemic. Preparedness strategies may be able to minimize future pandemic impacts by prioritizing rapid vaccine roll-out.

npj VaccinesVol. 10(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), École des Hautes Études en Santé Publique (FR), Pfizer (United States) (US), Arènes: politique, santé publique, environnement, médias (FR), Université de Rennes (FR)
Pfizer
Good health and well-being
Openalex Percentile: Top 7%
COVID-19 epidemiological studies
4.10
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Modeling the impact of early vaccination in an influenza pandemic in the United States — Charles H. Jones, Verna Welch, et al. · npj Vaccines (2025) | TGRS Research Map | TGRS